NEW YORK—Peppercom has been working with the former pharmaceutical technologies and services segment of Cardinal Health to launch it as an independent company, Catalent Pharma Solutions. Recently acquired by The Blackstone Group, Catalent— provider of advanced technologies, as well as development, manufacturing and packaging services for pharmaceutical, biotechnology, and consumer healthcare companies—announced its new identity on June 21.
Peppercom and Peppercom U.K. conducted a market audit consisting of internal and external research to refine and extend Catalent’s key corporate-level messaging and create press materials. The firm is also responsible for domestic and international media relations, as well as development of a thought leadership program.
“We looked for a partner with established knowledge in the business-to-business arena and in healthcare that would help us successfully launch our independent corporate identity, and help us raise awareness of the new identity in the marketplace,” says Cornell Stamoran, vice president of Catalent. “We chose Peppercom based on its experience in launching business-to-business companies, and its proven skill in healthcare.”